Bosniak category IIF designation and surgery for complex renal cysts.

PubWeight™: 1.63‹?› | Rank: Top 4%

🔗 View Article (PMID 19616809)

Published in J Urol on July 18, 2009

Authors

Rebecca L O'Malley1, Guilherme Godoy, Elizabeth M Hecht, Michael D Stifelman, Samir S Taneja

Author Affiliations

1: Division of Urologic Oncology, Department of Urology, New York University School of Medicine, New York, New York 10016, USA.

Articles by these authors

Robot assisted partial nephrectomy versus laparoscopic partial nephrectomy for renal tumors: a multi-institutional analysis of perioperative outcomes. J Urol (2009) 3.49

Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial. JAMA (2013) 3.40

Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. Eur Urol (2013) 3.34

Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol (2012) 3.30

The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur Urol (2010) 3.02

Ventricular diverticula on cardiac CT: more common than previously thought. AJR Am J Roentgenol (2007) 2.98

Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. Eur Urol (2011) 2.63

Multi-institutional analysis of robotic partial nephrectomy for hilar versus nonhilar lesions in 446 consecutive cases. Eur Urol (2010) 2.54

Robot assisted laparoscopic partial nephrectomy: initial experience. J Urol (2006) 2.35

Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology (2008) 2.34

The state of prostate MRI in 2013. Oncology (Williston Park) (2013) 2.33

National trends in the utilization of partial nephrectomy before and after the establishment of AUA guidelines for the management of renal masses. Urology (2013) 2.28

Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique? Eur Urol (2010) 2.27

Long-term follow-up of men with isolated high-grade prostatic intra-epithelial neoplasia followed by serial delayed interval biopsy. Urology (2010) 2.03

Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomy. J Urol (2005) 1.98

Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. Radiology (2009) 1.94

Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy. J Urol (2013) 1.90

Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy. J Urol (2010) 1.88

Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales. Radiology (2013) 1.86

Use of haemostatic agents and glues during laparoscopic partial nephrectomy: a multi-institutional survey from the United States and Europe of 1347 cases. Eur Urol (2007) 1.82

Pathologic outcomes of candidates for active surveillance undergoing radical prostatectomy. Urology (2010) 1.78

Evaluation of bowel distention and bowel wall appearance by using neutral oral contrast agent for multi-detector row CT. Radiology (2005) 1.78

Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trial. J Urol (2003) 1.67

Definition of biochemical recurrence after radical prostatectomy does not substantially impact prognostic factor estimates. J Urol (2010) 1.66

Endovascular treatment of spontaneous dissections of the superior mesenteric artery. J Vasc Surg (2009) 1.65

Perioperative complications of robot-assisted partial nephrectomy: analysis of 886 patients at 5 United States centers. Urology (2013) 1.63

Dual-energy CT in patients suspected of having renal masses: can virtual nonenhanced images replace true nonenhanced images? Radiology (2009) 1.63

Complications after robotic partial nephrectomy at centers of excellence: multi-institutional analysis of 450 cases. J Urol (2011) 1.62

Three differentiation states risk-stratify bladder cancer into distinct subtypes. Proc Natl Acad Sci U S A (2012) 1.60

Transperitoneal laparoscopic radical nephrectomy for large (more than 7 cm) renal masses. Urology (2008) 1.58

Extended pelvic lymph node dissection in robotic-assisted radical prostatectomy: surgical technique and initial experience. Urology (2010) 1.57

Transition zone prostate cancer: revisiting the role of multiparametric MRI at 3 T. AJR Am J Roentgenol (2015) 1.54

Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing. J Urol (2013) 1.53

Added value of multiplanar reformation in the multidetector CT evaluation of the female pelvis: a pictorial review. Radiographics (2009) 1.49

Clinical outcomes of primary bladder carcinoma in situ in a contemporary series. J Urol (2010) 1.48

The effect of changes in Medicare reimbursement on the practice of office and hospital-based endoscopic surgery for bladder cancer. Cancer (2010) 1.48

Laparoscopic radical nephrectomy: oncologic efficacy. Urol Clin North Am (2003) 1.47

Analysis of robotic-assisted laparoscopic pyleloplasty for primary versus secondary repair in 119 consecutive cases. Urology (2012) 1.46

Robot-assisted laparoscopic partial nephrectomy: the NYU technique. J Endourol (2005) 1.45

Dual-source computed tomography angiography image quality in patients with fast heart rates. J Cardiovasc Comput Tomogr (2009) 1.45

Does suspicion of prostate cancer on integrated T2 and diffusion-weighted MRI predict more adverse pathology on radical prostatectomy? Urology (2013) 1.42

Correction of prostate-specific antigen velocity for variation may improve prediction of cancer following prostate repeat biopsy. Can J Urol (2009) 1.39

Live robotic surgery: are outcomes compromised? Urology (2012) 1.38

Comparison of interreader reproducibility of the prostate imaging reporting and data system and likert scales for evaluation of multiparametric prostate MRI. AJR Am J Roentgenol (2013) 1.35

Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma. BJU Int (2011) 1.31

Followup interval prostate biopsy 3 years after diagnosis of high grade prostatic intraepithelial neoplasia is associated with high likelihood of prostate cancer, independent of change in prostate specific antigen levels. J Urol (2002) 1.29

Robotic reconstruction of the upper urinary tract. J Urol (2007) 1.29

3D nongadolinium-enhanced ECG-gated MRA of the distal lower extremities: preliminary clinical experience. J Magn Reson Imaging (2008) 1.27

Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. Eur Urol (2010) 1.26

Open Versus Laparoscopic Versus Robot-Assisted Laparoscopic Prostatectomy: The European and US Experience. Rev Urol (2010) 1.25

Robotic dismembered pyeloplasty: a 6-year, multi-institutional experience. J Urol (2008) 1.18

Prostate cancer: Comparison of 3D T2-weighted with conventional 2D T2-weighted imaging for image quality and tumor detection. AJR Am J Roentgenol (2010) 1.18

Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level alone. BJU Int (2008) 1.17

Dual-source versus single-source cardiac CT angiography: comparison of diagnostic image quality. AJR Am J Roentgenol (2009) 1.16

Radiologist, be aware: ten pitfalls that confound the interpretation of multiparametric prostate MRI. AJR Am J Roentgenol (2014) 1.16

Effect of warm ischemia time during laparoscopic partial nephrectomy on early postoperative glomerular filtration rate. J Urol (2009) 1.15

Role of MRI in minimally invasive focal ablative therapy for prostate cancer. AJR Am J Roentgenol (2011) 1.14

Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer. Radiology (2012) 1.12

Prostate cancer foci detected on multiparametric magnetic resonance imaging are histologically distinct from those not detected. J Urol (2012) 1.12

Screening for Prostate Cancer: A Review of the ERSPC and PLCO Trials. Rev Urol (2009) 1.12

Identification and characterization of ART-27, a novel coactivator for the androgen receptor N terminus. Mol Biol Cell (2002) 1.11

Racial disparity of epidermal growth factor receptor expression in prostate cancer. J Clin Oncol (2004) 1.10

The necessity of adrenalectomy at the time of radical nephrectomy: a systematic review. J Urol (2009) 1.08

Anatomy of the heart at multidetector CT: what the radiologist needs to know. Radiographics (2007) 1.08

Adenocarcinoma following urinary diversion. Can Urol Assoc J (2012) 1.07

Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis. J Urol (2013) 1.05

Dynamic contrast-enhanced MRI of the prostate with high spatiotemporal resolution using compressed sensing, parallel imaging, and continuous golden-angle radial sampling: preliminary experience. J Magn Reson Imaging (2014) 1.05

Renal involvement by chronic myelomonocytic leukemia requiring nephroureterectomy. Rev Urol (2009) 1.05

Robot-assisted laparoscopic partial cystectomy and diverticulectomy: initial experience of four cases. J Endourol (2008) 1.03

Prostate cancer: multiparametric MRI for index lesion localization--a multiple-reader study. AJR Am J Roentgenol (2012) 1.01

Is surveillance of small renal masses safe in the elderly? BJU Int (2009) 1.00

Near-infrared fluorescence imaging to facilitate super-selective arterial clamping during zero-ischaemia robotic partial nephrectomy. BJU Int (2012) 0.99

Granular cell tumor of scrotum: a rare tumor of the male external genitalia. Urology (2008) 0.98

Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy. J Urol (2009) 0.98

Hepatocellular carcinoma: assessment of response to transarterial chemoembolization with image subtraction. J Magn Reson Imaging (2010) 0.98

Differences in clinicopathologic features of prostate cancer between black and white patients treated in the 1990s and 2000s. Urology (2006) 0.98

Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation study. Clin Cancer Res (2009) 0.97

The role of lymphadenectomy in the surgical management of renal cell carcinoma. Urol Oncol (2004) 0.97

Neutral endopeptidase protein expression and prognosis in localized prostate cancer. Clin Cancer Res (2004) 0.97

Whole-lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy. J Magn Reson Imaging (2014) 0.97

Utility of MRI features for differentiation of retroperitoneal fibrosis and lymphoma. AJR Am J Roentgenol (2012) 0.96

Body and cardiovascular MR imaging at 3.0 T. Radiology (2007) 0.96

Opposed-phase MRI for fat quantification in fat-water phantoms with 1H MR spectroscopy to resolve ambiguity of fat or water dominance. AJR Am J Roentgenol (2006) 0.96

Changes in continence and erectile function between 2 and 4 years after radical prostatectomy. J Urol (2008) 0.96

Off-clamp robot-assisted partial nephrectomy preserves renal function: a multi-institutional propensity score analysis. Eur Urol (2012) 0.96

Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI. Eur Radiol (2010) 0.96

Time-resolved lower extremity MRA with temporal interpolation and stochastic spiral trajectories: preliminary clinical experience. J Magn Reson Imaging (2010) 0.95

Prostate cancer: utility of fusion of T2-weighted and high b-value diffusion-weighted images for peripheral zone tumor detection and localization. J Magn Reson Imaging (2011) 0.95

Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer? BJU Int (2009) 0.95

Management of localized prostate cancer and an incidental ureteral duplication with upper pole ectopic ureter inserting into the prostatic urethra. Rev Urol (2008) 0.95